Background: Type 2 diabetes mellitus has been reported during antipsychotic treatment.
Objective: To quantify the potential risk of treatment-emergent diabetes mellitus among patients receiving antipsychotic medications.
Methods: The MEDLINE and Psychinfo databases were searched using the key words antipsychotic (including individual drug names), diabetes, risk, and incidence for all English-language articles published between 1966 and 2005.